Spectral Medical, Inc. (EDT.TO)
1.11
-0.07
(-5.93%)
CAD |
TSX |
Oct 05, 15:59
Spectral Medical Gross Profit Margin (Quarterly) : -186.3% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -186.3% |
| March 31, 2026 | -229.1% |
| December 31, 2025 | -301.8% |
| September 30, 2025 | -165.2% |
| June 30, 2025 | -102.7% |
| March 31, 2025 | -358.7% |
| December 31, 2024 | -137.7% |
| September 30, 2024 | -240.6% |
| June 30, 2024 | -442.5% |
| March 31, 2024 | -127.2% |
| December 31, 2023 | -280.3% |
| September 30, 2023 | -325.2% |
| June 30, 2023 | -638.6% |
| March 31, 2023 | -104.3% |
| December 31, 2022 | -195.5% |
| September 30, 2022 | -261.0% |
| June 30, 2022 | -317.0% |
| March 31, 2022 | -238.6% |
| December 31, 2021 | -275.2% |
| September 30, 2021 | -487.8% |
| June 30, 2021 | -210.0% |
| March 31, 2021 | -126.3% |
| December 31, 2020 | -172.9% |
| September 30, 2020 | -177.0% |
| June 30, 2020 | -139.1% |
| Date | Value |
|---|---|
| March 31, 2020 | -146.9% |
| December 31, 2019 | -78.82% |
| September 30, 2019 | -115.0% |
| June 30, 2019 | -14.12% |
| March 31, 2019 | -55.58% |
| December 31, 2018 | 62.34% |
| September 30, 2018 | -30.57% |
| June 30, 2018 | -256.4% |
| March 31, 2018 | -9.80% |
| December 31, 2017 | -14.25% |
| September 30, 2017 | -8.54% |
| June 30, 2017 | 7.96% |
| March 31, 2017 | -25.16% |
| December 31, 2016 | 15.63% |
| September 30, 2016 | -36.93% |
| June 30, 2016 | -28.16% |
| March 31, 2016 | -34.84% |
| December 31, 2015 | -67.41% |
| September 30, 2015 | -54.64% |
| June 30, 2015 | -31.91% |
| March 31, 2015 | -27.02% |
| December 31, 2014 | -35.19% |
| September 30, 2014 | -59.10% |
| June 30, 2014 | -35.60% |
| March 31, 2014 | -59.72% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Resverlogix Corp. | -- |
| Theratechnologies, Inc. | -- |
| COSCIENS Biopharma, Inc. | 55.27% |
| Restart Life Sciences Corp. | -213.3% |
| Covalon Technologies Ltd. | 65.12% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -650.4% |
| Profit Margin (Quarterly) | 53.30% |
| Operating Margin (Quarterly) | -352.3% |
| Return on Net Operating Assets | -2.37K% |